Filter

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 5 of 5 items for :

Clear All
José V Lima Jr Department of Medicine, Division of Endocrinology and Metabolism, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil
Santa Casa de São Paulo School of Medical Sciences, São Paulo, SP, Brazil
Fleury Group, São Paulo, SP, Brazil

Search for other papers by José V Lima Jr in
Google Scholar
PubMed Close
,
Nilza M Scalissi Santa Casa de São Paulo School of Medical Sciences, São Paulo, SP, Brazil

Search for other papers by Nilza M Scalissi in
Google Scholar
PubMed Close
,
Kelly C de Oliveira Department of Medicine, Division of Endocrinology and Metabolism, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil

Search for other papers by Kelly C de Oliveira in
Google Scholar
PubMed Close
,
Susan C Lindsey Department of Medicine, Division of Endocrinology and Metabolism, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil

Search for other papers by Susan C Lindsey in
Google Scholar
PubMed Close
,
Caroline Olivati Fleury Group, São Paulo, SP, Brazil

Search for other papers by Caroline Olivati in
Google Scholar
PubMed Close
,
Elisa Napolitano Ferreira Fleury Group, São Paulo, SP, Brazil

Search for other papers by Elisa Napolitano Ferreira in
Google Scholar
PubMed Close
, and
Claudio E Kater Department of Medicine, Division of Endocrinology and Metabolism, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil

Search for other papers by Claudio E Kater in
Google Scholar
PubMed Close

). Cluster 2 has signature activation of MAP kinase signaling pathways. The following genes stand out: NF1, RET, HRAS, and TMEM127 (9–11). Cluster 3 (identified by The Cancer Genome Atlas) has WnT pathways based on a transcriptional signature, which

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EO-22-0091
Volume/Issue:
Volume 3: Issue 1
Open access
Christie G Turin Department of Medicine, Division of Endocrinology, Metabolism and Diabetes, University of Colorado, Aurora, Colorado, USA

Search for other papers by Christie G Turin in
Google Scholar
PubMed Close
,
Molly M Crenshaw Department of Pediatrics, Combined Pediatrics-Medical Genetics Residency Program, University of Colorado, Aurora, Colorado, USA

Search for other papers by Molly M Crenshaw in
Google Scholar
PubMed Close
, and
Lauren Fishbein Department of Medicine, Division of Endocrinology, Metabolism and Diabetes, University of Colorado, Aurora, Colorado, USA
Division of Biomedical Informatics and Personalized Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA

Search for other papers by Lauren Fishbein in
Google Scholar
PubMed Close

% NF1 Autosomal dominant 7.7–14% +++ + + ++ ~12% SDHB Autosomal dominant 22–26% by age 60 ++ ++ +++ ++ 25–50% SDHD Autosomal dominant – paternal inheritance 43% by age 60 ++ +++ ++ +++ 3

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EO-22-0044
Volume/Issue:
Volume 2: Issue 1
Open access
Sofia Maria Lider Burciulescu CI Parhon National Institute of Endocrinology, Bucharest, Romania

Search for other papers by Sofia Maria Lider Burciulescu in
Google Scholar
PubMed Close
,
Caren Randon Department of Thoracic and Vascular Surgery, Ghent University Hospital & Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, UGent, Ghent, Belgium

Search for other papers by Caren Randon in
Google Scholar
PubMed Close
,
Frederic Duprez Department of Radiotherapy-Oncology, Ghent University Hospital, Ghent Belgium & Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, UGent, Ghent, Belgium

Search for other papers by Frederic Duprez in
Google Scholar
PubMed Close
,
Wouter Huvenne Department of Head and Neck Surgery, Ghent University Hospital & Department of Head & Skin, Faculty of Medicine and Health Sciences, UGent, Ghent, Belgium

Search for other papers by Wouter Huvenne in
Google Scholar
PubMed Close
,
David Creytens Department of Pathology, Ghent University Hospital, Ghent University & Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, UGent, Ghent, Belgium

Search for other papers by David Creytens in
Google Scholar
PubMed Close
,
Kathleen B M Claes Center for Medical Genetics, Ghent University Hospital & Department of Biomolecular Medicine, Faculty of Medicine and Health Sciences, UGent, Ghent, Belgium

Search for other papers by Kathleen B M Claes in
Google Scholar
PubMed Close
,
Robin de Putter Center for Medical Genetics, Ghent University Hospital & Department of Biomolecular Medicine, Faculty of Medicine and Health Sciences, UGent, Ghent, Belgium

Search for other papers by Robin de Putter in
Google Scholar
PubMed Close
,
Guy T’Sjoen Department of Endocrinology, Ghent University Hospital & Department of Internal Medicine & Pediatrics, Faculty of Medicine and Health Sciences, UGent , Ghent, Belgium

Search for other papers by Guy T’Sjoen in
Google Scholar
PubMed Close
,
Corin Badiu CI Parhon National Institute of Endocrinology, Bucharest, Romania
Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

Search for other papers by Corin Badiu in
Google Scholar
PubMed Close
, and
Bruno Lapauw Department of Endocrinology, Ghent University Hospital & Department of Internal Medicine & Pediatrics, Faculty of Medicine and Health Sciences, UGent , Ghent, Belgium

Search for other papers by Bruno Lapauw in
Google Scholar
PubMed Close

included the most frequently mutated genes in PPGL: RET, VHL, NF1, MAX, SDHA, SDHB, SDHC, SDHD, SDHAF2, and TMEM127 . Depending on phenotypic features and/or year of diagnosis, patients were tested for a variable number of these genes. For patients with

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EO-22-0040
Volume/Issue:
Volume 3: Issue 1
Open access
Katherine A English OCDEM, Radcliffe Department of Medicine, University of Oxford, Churchill Hospital, Oxford, UK

Search for other papers by Katherine A English in
Google Scholar
PubMed Close
,
Rajesh V Thakker OCDEM, Radcliffe Department of Medicine, University of Oxford, Churchill Hospital, Oxford, UK
Oxford NIHR Biomedical Research Centre, Oxford University Hospitals Trust, Oxford, UK

Search for other papers by Rajesh V Thakker in
Google Scholar
PubMed Close
, and
Kate E Lines OCDEM, Radcliffe Department of Medicine, University of Oxford, Churchill Hospital, Oxford, UK
Oxford NIHR Biomedical Research Centre, Oxford University Hospitals Trust, Oxford, UK

Search for other papers by Kate E Lines in
Google Scholar
PubMed Close

–Lindau tumour-suppressor ( VHL ), TSC complex ( TSC ) , neurofibromin 1( NF1 ), MutY DNA glycosylase, BRCA2 DNA repair-associated, cyclin-dependent kinase inhibitor 1B ( CDKN1B ), and checkpoint kinase 2 genes ( Crona & Skogseid 2016 , Scarpa et al. 2017

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EO-23-0003
Volume/Issue:
Volume 3: Issue 1
Open access
Catherine M Skefos The University of Texas MD Anderson Cancer Center, Clinical Cancer Genetics Program, Houston, Texas, USA

Search for other papers by Catherine M Skefos in
Google Scholar
PubMed Close
,
Pamela L Brock The Ohio State University College of Medicine, Division of Human Genetics, Comprehensive Cancer Center, Columbus, Ohio, USA

Search for other papers by Pamela L Brock in
Google Scholar
PubMed Close
,
Erica Blouch Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA

Search for other papers by Erica Blouch in
Google Scholar
PubMed Close
, and
Samantha E Greenberg Department of Health Care Sciences, UT Southwestern Medical Center, Dallas, Texas, USA

Search for other papers by Samantha E Greenberg in
Google Scholar
PubMed Close

. PVs in RET, FH, VHL, NF1 , and other genes are also known to increase the risk of PGL and/or PCC. Although individuals with hereditary PPGL syndrome may develop any SDHx - related tumors, the penetrance and phenotype of hereditary PPGL syndrome

Article Type:
Commentary
DOI:
https://doi.org/10.1530/EO-23-0043
Volume/Issue:
Volume 4: Issue 1
Open access